This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources March 29, 2011
ASCLS eNewsBytes
March 29, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

Privacy in the era of EHRs — What's the lab's responsibility?
Clinical Laboratory News    Share   Share on FacebookTwitterShare on LinkedinE-mail article
The federal government, as well as many in health care, have touted the move to electronic health records (EHR) as key to boosting more coordinated and efficient care. Starting this year, physicians and hospitals can begin cashing in on government incentives for deploying EHRs, and regulators have made it clear that lab data is a critical component. More

Clinical pathology labs are on track to get new genetic test that screens for 448 rare childhood diseases
DARK Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Rapidly-evolving molecular diagnostics technology is about to trigger a major expansion in preconception genetic testing. In turn, this could benefit clinical laboratories and pathology groups as they begin to offer these genetic tests to help prospective parents screen their DNA for recessive gene mutations that cause 448 deadly childhood diseases in offspring. More

Genome map of multiple myeloma offers clues to its cause
HealthDay News via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The genome of the highly aggressive blood cancer multiple myeloma has been mapped by a team of North American scientists, who say their achievement, will improve understanding of what causes the disease and may lead to new treatments. "For the first time, we are able to see on a molecular basis what might be causing this malignancy," said Dr. David S. Siegel, chief of the multiple myeloma division at the John Theurer Cancer Center at Hackensack University Medical Center in New Jersey. More
Related stories:
FDA approves the first melanoma drug to extend life (TIME)

ACOG updates cystic fibrosis screening guidelines
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The American College of Obstetricians and Gynecologists' (ACOG's) Committee on Genetics has updated its 2001 guidelines for cystic fibrosis screening practices among obstetrician-gynecologists, according to a Committee Opinion published in Obstetrics & Gynecology. The updated recommendations state that as a routine part of obstetric care and regardless of ethnicity, all women of reproductive age should be offered preconception and prenatal cystic fibrosis carrier screening. More

Qualiris by Stago

Qualiris by Stago is a Web-based External Quality Assessment program used to provide enhanced confidence for your hemostasis testing. Qualiris provides peer-group, result comparisons from a global to a local level. Stago's dedicated experts are available 24/7 to help interpret your results. For more information on Quadfsliris visit

Progress seen in creating eye cells from stem cells: Lab success may someday help people with macular degeneration
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
To push the theoretical promise of stem cell research into the world of viable treatments, scientists have successfully fashioned adult stem cells into the kind of eye cells that fall victim to the onset of age-related macular degeneration, or AMD. The work did not involve embryonic stem cells, which have been the subject of much debate in recent years, but rather so-called "human-induced pluripotent stem cells." More

Mysterious digestive disease peaks in the summer
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Summertime sees the greatest number of patients hospitalized for a common and sometimes painful digestive problem called diverticulitis, a new study finds. The results are puzzling researchers already stumped by this disease. "It's been a mystery for a number of years," said study author Dr. Rocco Ricciardi, adding that nobody knows for sure what triggers the problem. More

Drug-resistant bacterium hits Southland health care facilities
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers find 356 cases of carbapenem-resistant Klebsiella pneumoniae, mostly among elderly. It's a relative of E. coli, resistant to most antibiotics except colistin, a drug so powerful it can cause kidney damage. Studies in the U.S. and Israel have shown about 40 percent of infected patients die. More

Anemia in postmenopausal women associated with poor nutrition
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Anemia is linked to poor nutrition in postmenopausal women, according to a recent observational study of the Women's Health Initiative. According to the researchers, nutritional anemia includes those types associated with prolonged inadequate intake of folate, vitamin B12, iron, protein, and vitamin C. More

NCCN: Molecular testing has a long way to go
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Molecular testing in cancer is "an immature industry," according to a prominent oncologist participating in a panel discussion of the testing here at the National Comprehensive Cancer Network (NCCN) 16th Annual Conference. The panel told tales of runaway testing, mysterious billing, underregulation, confused patients, scarce phase 3 trials, and impractical logistics. More

Protein microarrays and novel detection platforms
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The field of proteomics has undergone rapid advancements over the last decade and protein microarrays have emerged as a promising technological platform for the challenging task of studying complex proteomes. This gel-free approach has found an increasing number of applications due to its ability to rapidly and efficiently study thousands of proteins simultaneously. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes.
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!


Colby Horton, Vice President of Publishing

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor

Recent Issues

  • March 22, 2011
  • March 15, 2011
  • March 8, 2011
  • March 1, 2011
  • Dedicated - Bio-Rad
  •  RSS Feed
    Most popular articles